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ABSTRACT 
Constitutive genes are detected in cells in basal conditions. Stimuli such as reactive oxygen 
species (ROS) may up-regulate the expression of these genes, but the mechanisms involved in their 
continuous basal expression are unknown. As ROS concentrations are tightly maintained at 
intracellular level, we hypothesize that basal levels of ROS could be responsible for the expression of 
these constitutive genes. In this report, we analyze the regulation of an important constitutive gene, 
TGF-β1, after decreasing intracellular ROS concentration in human mesangial cells. Decreased 
intracellular hydrogen peroxide by catalase addition reduced basal TGF-β1 protein, mRNA expression 
and promoter activity. Furthermore, catalase decreased the basal activity of Activated Protein-1 (AP-
1) that regulates TGF-β1 promoter activity. This effect disappeared when AP-1 binding site was 
removed. Similar results were observed with proteins whose promoter regions contains AP-1 binding 
sites as eNOS, but not with other constitutive genes as COX1 or PKGα, without AP-1 sites in their 
promoter. Pharmacological inhibition of ROS synthesis by blocking of NADPH oxidase, respiratory 
chain or xanthine oxidase induced a significant reduction of basal ROS concentration, similar to the 
observed with catalase. Similar changes were detected in human fibroblasts mutated in mitochondrial 
DNA. In any of these conditions, TGF-β1 expression decreased except with xanthine oxidase 
blockaded.  
These findings suggest a novel role for the steady-state basal intracellular ROS concentration, 
which could be essential for the basal expression of constitutive AP1-dependent genes, as TGF-β1. 
Moreover, the different systems involved in the production of ROS could play different roles on this 
regulation. 
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Introduction 
Genes are considered as constitutive when they are transcribed at relatively constant levels in 
cells under basal conditions. Unlike inducible genes, that are transcribed only when they are needed as 
a consequence of specific stimuli, constitutive genes are expressed continuously in cells, and it seems 
that they play significant roles in the maintenance of basic cell processes. Although the transcription 
level of constitutive genes seems to be rather constant, it has been reported that they can be also 
regulated by different stimuli, such as reactive oxygen species (ROS) (7,12,18,27,43). 
ROS consist of a variety of oxygen-derived small molecules with diverse structures. Some of 
these species, such as superoxide and hydroxyl radicals, are extremely unstable, whereas others like 
hydrogen peroxide (H2O2) are relatively long-lived and freely diffusible (7). They are generated in 
cells as a consequence of their basal function, as they are synthesized by a wide variety of enzymatic 
systems such as NAD(P)H oxidase, xanthine oxidase and arachidonic acid metabolizing enzymes as 
well as by the mitochondrial respiratory chain (7,26,38,41). Degradation of these ROS is also 
regulated by antioxidant enzymes, including superoxide dismutase, catalase (CAT) and glutathione 
peroxidase, among others. The balance between production and elimination is tightly regulated and 
ensures the proper maintenance of cellular metabolism and homeostasis. In general, moderate levels 
of ROS are involved in biological processes such as cell proliferation, differentiation and survival 
(11,37). Exogenous stimuli may also modulate ROS balance and in these cases transient ROS 
production can act as an intracellular signalling mechanism, regulating a broad variety of genes and 
cell functions (2,31,39). Among ROS, H2O2 is best studied as a second messenger. It mainly acts in 
the cells by modifying critical residues of proteins thereby regulating their catalytic activities or other 
functions (7,40).  
TGF-β1 is a member of a large family of growth and differentiation factors that are involved 
in cell division, differentiation, migration, adhesion, death, extracellular matrix production, tissue 
homeostasis and embryogenesis (20,28,33). It express constitutively in a wide variety of cell types. 
TGF-β1 has a crucial role in tissue homeostasis and the disruption of the TGF-β1 pathway has been 
implicated in many human diseases, including cancer, autoimmune, fibrotic and cardiovascular 
diseases (20,29). Previous reports have showed that ROS can regulate TGF-β1 synthesis 
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(5,12,17,23,25,32) also through the activation of the transcription factor AP-1 (12). Taking into 
account this fact, we hypothesized that basal concentrations of ROS could be involved in the 
constitutive expression of TGF-β1. 
Present experiments were devoted to analyze this hypothesis. Additional, the possible 
mechanisms involved in the observed effects were studied. Finally, the possibility of the different 
sources of ROS could play different roles in the regulation of the constitutive expression of TGF-β1 
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Results 
CAT-dependent reduction of intracellular H2O2 decrease TGF-β1 protein content in human 
mesangial cells (HMC). 
In order to reduce the basal levels of H2O2, HMC were incubated for 16 h with various CAT 
concentrations. As previously reported (24,34), the intracellular CAT activity significantly increased 
(Fig. 1A) and a dose-dependent reduction of intracellular ROS concentration, measured by flow 
cytometry with fluorescent dye DCFHDA, was observed (Fig. 1B). As controversy exists regarding 
the specificity of this dye for H2O2, we pursued cellular imaging approaches to analyze intracellular 
H2O2 concentration using the biosensor HyPer (1), transfected into HMCs. Briefly, HyPer is 
a genetically encoded, highly specific fluorescent probe for detecting H2O2 inside living cells. This 
probe consists of circularly permuted yellow fluorescent protein (cpYFP) inserted into the regulatory 
domain of the prokaryotic H2O2-sensing protein, OxyR. Sensitivity of the probe is sufficient to 
observe H2O2 increase upon physiological conditions (1,13). The incubation of cells with H2O2 
significantly increased the fluorescent signal, whereas CAT incubation suppressed the basal H2O2 
generation (Fig. 1C). 
In these conditions of CAT-dependent reduction of intracellular H2O2, TGF-β1 protein 
synthesis was evaluated by three means. Figure 2A shows a dose-dependent reduction of TGF-β1 
protein evaluated by immunoblot. When TGF-β1 content was analyzed in intact cells by 
immunofluorescence, CAT also reduced this protein (Fig. 2B). Finally, total immunoreactive TGF-β1, 
measured by ELISA, decreased in the supernatants of HMC incubated with CAT (Fig. 2C). Phorbol 
12-myristate13-acetate (PMA), a potent stimulus for TGF-β1 synthesis (9) was used as positive 
control (Fig. 2,B-C).  
 
Mechanisms involved in the CAT-dependent reduction of TGF-β1 protein content in human 
mesangial cells (HMC). 
As we previously demonstrated that H2O2 augmented TGF-β1 protein synthesis by increasing 
the steady-state levels of its mRNA (12), we first analyzed mRNA expression by quantitative-RT-
PCR after catalase addition to HMC. We could observe a significant decrease of mRNA expression 
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(Fig. 3A). This reduction seemed to be due to the CAT-dependent reduction of the TGF-β1 promoter 
activity, evaluated by measuring of luciferase activity in cells transfected with constructions in which 
luciferase was under the control of the TGF-β1 promoter (Fig. 3B). Since this promoter contains at 
least two AP-1 binding sequences (15) and it is also regulated by ROS (21,30,38), we analyzed the 
activity of TGF-ß1 promoter after deletion of different response sites, in order to test the implication 
of AP-1 on the decreased TGF-β1 promoter activity under CAT treatment. As shown in Figure 3C, 
CAT inhibited the activity of the complete promoter, as well as the construction containing AP-1 site 
(phTG5), but did not modify activity in cells transfected with the plasmid phTG6, that did not contain 
the consensus sequence for AP-1.   
 In order to ensure the implication of AP-1 in TGF-β1 down-regulation induced by CAT, we 
analyzed CAT ability to modulate the basal activity of this transcription factor. For this purpose, 
EMSA assays were performed in HMC incubated with different CAT concentrations. As shown in 
Figure 3D, a significant dose-dependent reduction of the interaction between AP-1 specific 
oligonucleotide and nuclear proteins occurred after CAT addition. This finding was confirmed by 
studying the activity of the 3TP-Lux plasmid, a construction in which luciferase activity is under the 
control of three AP-1 sites, in HMC treated with CAT. Again, CAT induced a dose-dependent 
decrease of the activity of this plasmid (Fig. 3E). 
Considering together these results, it appears that basal intracellular concentration of ROS 
regulates the activity of AP-1 transcription factor, with the subsequent activation of genes under the 
control by this factor, particularly TGF-β1. To ascertain this hypothesis, the ability of CAT to 
modulate other proteins with different regulatory elements in their promoters was tested. The results 
are collected in Figure 4. Catalase-dose-dependent decrease in eNOS protein content was observed in 
endothelial cells (Fig. 4A), whereas no changes in cyclooxygense-1 (Fig. 4B) and protein kinase Gα1 
(Fig. 4C) protein content were detected in HMC.  
 
Importance of the different systems that synthesizes ROS in the basal TGF-β1 expression in HMC 
To study the influence of different sources of ROS in the maintenance of the TGF-β1 levels, 
cells were incubated with pharmacological inhibitors of NADPH oxidase (diphenyleneiodonium, DPI, 
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10µM), mitochondrial electron-transport chain complex I (rotenone, ROT, 10µM), and xanthine 
oxidase (allopurinol, ALLO, 100 µM). The results were compared with those from 320 U/mL CAT. 
After treatments, ROS and H2O2 concentration was evaluated by flow cytometry in cells loaded with 
DCFHDA and by confocal microscopy in cells transfected with HyPer. A relevant and similar 
suppression of basal ROS and H2O2 synthesis was observed in all cases and the inhibition was 
comparable to that of CAT (Fig. 5A-B). In these conditions of reduced H2O2 intracellular levels, only 
DPI and ROT inhibited TGF-β1 and 3TP-Lux promoter activity (Fig. 5C), as well as TGF-β1 content 
in cell supernatants (Fig. 5D). However, ALLO did not modify any of these parameters (Fig. 5C-D). 
 As these experiments were performed with pharmacological inhibitors, we tried to confirm 
some results by using genetically modified cells. Human fibroblasts mutated in mitochondrial DNA 
(G7896A) (3) were used to analyse the ability of a defect in the respiratory chain to modulate the 
basal TGF-β1 cellular expression. In these cells, a decreased concentration of the cytokine in cell 
extracts (Fig. 6A) and in supernatants (Fig. 6B) was observed, when compared with their control cells. 
Additionally, when cells were transfected with the HyPer plasmid, they exhibited a lower H2O2 
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Discussion 
The ability of increased ROS to modulate different aspects of cell function has been widely 
recognized (11,26,37,38,40). Our group has contributed to the knowledge of this regulation by 
demonstrating that H2O2 induces mesangial cell contraction (6), stimulates cell proliferation (8) and 
increases extracellular matrix proteins via TGF-β1 (12). However, the experiments devoted to analyze 
the role of ROS in cell function have been systematically performed by increasing ROS concentration, 
directly or through mechanisms that stimulate their endogenous synthesis. Resting cells synthesize a 
significant amount of ROS via mitochondrial electron-transport chain that is maintained under control 
by antioxidant enzymes (26). We wondered if these ROS could play some role in the basic functions 
of resting cells, such as the expression of constitutive genes. As we demonstrated that increased ROS 
stimulates TGF-β1 (12), we chose this gene to analyze our hypothesis, as we supposed that the 
opposite effect could be also possible.  
To decreased intracellular ROS concentration, CAT was added to the extracellular media of 
the cells. Extracellular CAT decreases H2O2 in cell supernatants, with the subsequent transfer of this 
ROS from the intra to the extracellular media, but also penetrates into the cells (24,34). Our 
experiments confirm that intracellular CAT activity increased about three-fold after addition of 320 
U/ml CAT to the cell supernatants for 16 h. Moreover, they confirmed that intracellular ROS 
concentration decreased about 40% with this same CAT concentration, measured by fluorescence of 
DCFHDA. Although this dye has been proposed as specific for H2O2, it seems that it may be also 
activated by other ROS (4). Thus, to be sure about changes in H2O2 elicited by extracellular CAT, we 
transfected the cells with the HyPer plasmid (1), that specifically responds to changes in H2O2 
concentrations and we confirmed the significant decrease of intracellular H2O2 by CAT addition.  
Cells with low intracellular H2O2 concentration did not show any significant toxicity, at least 
in the intervals that these studies were performed. However, the intracellular concentration of TGF-
β1, the release of this cytokine to cell supernatants, the steady-state levels of its mRNA and its 
promoter activity significantly decreased in the cells. The quantitative changes observed in these 
parameters were comparable to the reduction in H2O2 concentration. Thus, the presence of 320U/ml 
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CAT in the extracellular media decreased about 50% of TGF-β1 protein content evaluated by 
immunoblot and TGF-β1 mRNA quantified by RT-PCR. 
Present experiments suggest that the decreased TGF-β1 promoter activity, consequence of the 
decreased H2O2 intracellular concentration, is the basic mechanism that leads to the TGF-β1 down-
regulation. Since this promoter is under the control of different transcription factors (16), we tried to 
perform a general approach of these factors by analyzing the transcriptional activity of continuous 
deletions of the promoter. The complete deletion of the region between -1362 and -453 did not modify 
the promoter response to CAT addition, but when the deleted region included the fragment between -
453 and -323 the CAT inhibition disappeared. In this region is located the specific DNA sequence that 
binds AP-1 thus supporting the relevance of this transcription factor in the genesis of the observed 
effects. In fact, the binding of AP-1 to cellular extracts progressively decreases in cells incubated with 
increasing concentrations of CAT, as well as the activity of 3TP-Lux construction, which specifically 
activates in response to AP-1. This was a rather expected result, as this factor seems to be one of the 
most relevant transcription factors involved in TGF-β1 regulation (16,30), and it is up-regulated by 
ROS over-production (14,21,30,38).  
These experiments support the role of the basal AP-1 activity on the basal expression of TGF-
β1, under the control of intracellular steady-state levels of H2O2. If AP-1 were so critical in the 
regulation of this process, genes under its control would have behaviours similar to TGF-β1, and the 
lack of response elements to AP-1 in the promoter region would determine lack of response to CAT 
treatment. For this purpose we analysed other proteins.  The cellular content of eNOS decreased when 
endothelial cells were incubated with CAT, whereas no changes were observed in COX1 and PKG-α1 
content in HMC after treatment with CAT. From these three proteins, only eNOS contains AP1-site in 
their promoter region (22,35,42). 
ROS are derived from several compartments inside the cells: mitochondria, peroxisomes, 
plasma membrane, endoplasmic reticulum, Golgi complex, lysosomes and the nucleus, where there 
are enzyme systems that synthesize ROS (7,26,37). Although this synthesis is usually considered as a 
whole, probably the different enzymes are responsible for ROS production for specific cellular 
functions. Regarding the basal activity of AP-1 we tested the possibility that it could depend on the 
GONZÁLEZ-RAMOS ET AL. 
 10 
mitochondrial synthesis of ATP or in two well studied enzymatic systems, NADPH oxidase or 
xanthine oxidase. Interestingly, only the pharmacological blockade of mitochondrial function and 
NADPH oxidase reproduce the TFG-β1 down-regulation elicited by CAT, although a similar 
reduction in ROS concentration was observed with the different pharmacological inhibitors tested. 
These findings allow us to speculate. Although different metabolic and enzymatic systems are 
active in resting cells, only some of them, as ATP synthesis by mitochondria or NADPH oxidase are 
responsible for the ROS production that regulates basal AP-1 activity. In this context, we have 
performed some experiment in cells with genetically-determined deficient mitochondrial activity. In 
these cells, which exhibit decreased H2O2 intracellular concentrations, the synthesis of TGF-ß1 is 
significantly reduced. 
Present results support the hypothesis that endogenous ROS help to maintain the basal 
expression of some constitutive genes, such as TGF-β1 or eNOS, through the regulation of the 
activity of the transcription factor AP-1. H2O2 could be the most relevant ROS involved in this 
regulation. Although more studies will be necessary, our results point to the possibility that different 
sources of ROS production can have different roles in gene regulation, supporting the idea of the 
functional compartmentalization of ROS. Understanding these mechanisms is relevant because of 
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Innovation  
This is the first time that a role for intracellular ROS steady-state levels in the basal 
expression of constitutive genes is proposed. Our findings suggest that basal levels of intracellular 
ROS regulate the activity of the transcription factor AP-1, and subsequently of the genes under its 
control, particularly TGF-ß1 in HMC and eNOS in endothelial cells. Moreover, our data suggest that 
the source of ROS may be relevant in this regulation. Interestingly, ATP synthesis by mitochondria 
seems to be one of the sources involved, suggesting a link between constitutive gene expression and 
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Materials and Methods  
Materials 
Culture media were from Lonza (Basel. Switzerland). Foetal bovine serum (FBS), antibiotics, 
goat anti-Rabbit, gold antifade reagent and lipofectamine were from Invitrogen (San Diego, CA). 
Fluorescent probe dichlorodihydrofluorescein-diacetate (DCFH-DA) were from Molecular Probes 
(Eugene, OR). Human TGF-β1 and cyclooxigenase-1 antibodies were from Santa Cruz (La Jolla, 
CA). AntiPKG-1α antibody was from Cell Signalling (Danvers, MA); anti-eNOS antibody from 
Transduction Laboratories (Palo Alto, CA) and anti-rabbit horseradish peroxidase antibody from 
Chemicon (Billerica, MA).Catalase assay kit was from Cayman Chemical (Ann Arbor, MI). Dual-
Luciferase Reporter Assay System and ELISA kit were from Promega (Madison, WI). Radioactivity 
(γ-32P)-ATP was from Amersham (Buckinghamshire, UK). Other antibodies and reagents were from 
Sigma Chemical Company (St. Louis, MO). 
 
Cell culture and treatment 
Human mesangial cells (HMC) were prepared as described in (12,10). The experiments were 
performed in cells on passages 3-7. Human endothelial cells, EAHY926 were from American Type 
Culture Collection (Rockville, MD). Human fibroblasts from skin were provided by Dr Garesse. They 
have a mutation G7896A in the subunit II of cytochrome c oxidase (3). Fibroblasts from healthy 
individuals were used as control.  
Cells were maintained in culture medium supplemented with 100 units/ml penicillin, 100 
µg/ml streptomycin and 10% FBS. In the case of human fibroblasts, 50µg/ml uridine was also added. 
Cells were serum-deprived for 24 h and then they were incubated for 16 h with catalase (160 U/ml-
640 U/ml) prepared as recommended by 36. In some experiments HMC were incubated for 16 h with 
diphenyleneiodonium (DPI, 10µM), rotenone (ROT, 10µM), and allopurinol (ALLO, 100 µM). Cell 
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Measurement of intracellular CAT activity and ROS concentration 
For determination of catalase enzymatic activity, cells were scraped off in PBS, pelleted by 
centrifugation for 10 min at 1500 rpm at 4◦C, resuspended in 50 mmol/l potassium phosphate, pH 7 
and sonicated for two 15s bursts. Lysates were clarified by centrifugation at 13,000g for 10 min at 4◦C 
and supernatants were used to determine catalase activity using catalase assay kit. 
ROS production was determined by two methods. First, flow cytometry was used in cells 
loaded with dichlorodihidrofluorescin, DCFHDA (5 mmol/l, 60 min). Cells were detached by 
trypsinization after treatments and cellular fluorescence intensity was measured by using FACScan 
flow cytometer (Becton Dickinson, NJ). For each analysis, 10,000 events were recorded and cell 
viability was controlled with propidium iodide. ROS production was calculated as percentage of 
DCFHDA fluorescence intensity with respect to untreated cells. Second, cells were transfected with 
1µg of HyPer plasmid (1) with lipofectamin. Twenty-four hours after transfection, cells were serum 
deprived for 24 h and then treated. The analysis of the plasmid expression was performed by using a 
confocal laser scan microscopy LEICA TCS-SL (Heidelberg, Germany). Hydrogen peroxide (100µM) 
was added to the cells as control of plasmid induction. 
 
Protein extraction and immunoblot analysis 
Immediately after treatments, cells were washed with cold PBS and lysed in lysis buffer (50 
mM Trizma, pH 8.0, 150 mM NaCl, 0.1% Triton X-100, 10 mM EDTA, 0.25% sodium deoxycholate 
and protease inhibitors). Cell lysates were sonicated and proteins were resolved onto 8–12 % SDS-
polyacrylamide gels. The proteins were transferred to PVDF membrane, blocked with 5% non-fat dry 
milk in TBS-T (50 mM Trizma, pH 7.6, 150 mM NaCl, 0.1% Tween-20) and incubated overnight at 
4◦C with the corresponding primary antibodies and 1h at room temperature with secondary antibodies. 
Immunolabeling was detected by enhanced chemiluminescence. 
 
Immunofluorescence analysis 
After treatment, cells were fixed with 4% paraformaldehyde in PBS, 10 min at room 
temperature, rinsed and permeabilized with 0.5% Triton X-100 in PBS (10 min). Cells were then 
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incubated for 1h with 3% BSA in PBS to block nonspecific binding. Afterwards, cells were incubated 
overnight at 4◦C with anti-TGF-β1 antibody (1:50) and then rinsed with PBS. Finally, cells were 
incubated with goat anti-Rabbit IgG (1:500) for 1h in the darkness. Slides were washed and mounted 
with Gold antifade Reagent. Colour detection was performed by confocal microscopy. 
 
Measurement of immunoreactive TGF-β1 by ELISA. 
Culture medium (250 µl) from treated cells was removed from each well and incubated with 5 
µl 1N HCl for 15 min to activate latent TGF-β1. After, supernatants were neutralized with 1N NaOH. 
Samples were analyzed with a commercial TGF-β1 ELISA kit (19). Protein concentrations were 
determined spectrophotometrically. Each sample was measured in duplicate and the results were 
expressed as pg of TGF-β1 per µg of protein. 
 
Analysis of total TGF-ß1 mRNA by quantitative RT-PCR  
Total RNA from each sample was extracted and quantified. Two micrograms of total RNA 
was reverse transcribed to cDNA (High Capacity cDNA Reverse Transcription Kit, Applied 
Biosystem). 250 ng of cDNA was analyzed for TGF-β1 (Hs00171257_m1) and GAPDH (4326317E) 
as endogenous control by using TaqMan gene expression Assays (Applied Biosystem). The 
normalized gene expression method (2-ΔΔCT) for relative quantification of gene expression was used. 
 
Transient transfections and assay of luciferase activity 
Complete promoter region of the human TGF-β1 gene linked to the luciferase reporter gene 
and deletion mutants were kindly provided by Dr. Kim (Bethesda, MD). Specifically, luciferase-
linked deletion mutants used were: phTG5, which lacks negative regulatory regions located between 
−1362 and −1132 and from −731 to −453 positions and an enhancer element located from −1132 to 
−731 region, but does contain the AP-1 consensus sequence; phTG6, which lacks AP-1 site (16). An 
AP-1–sensitive promoter (3TP-Lux) and cytomegalovirus-renilla were also used.   
Subconfluent (60%) cells were incubated 6 h with 0.5 µg TGF-β1 or 3TP-Lux plasmids, 0.05 
µg cytomegalovirus-Renilla and 5µl lipofectamin reagent. After serum deprivation for 24 h, cells were 
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treated and then lysed. Luciferase activity was measured with a commercial Dual-Luciferase Reporter 
Assay System according to the manufacturer’s recommendations. Results were expressed as 
percentage of luciferase activity with 100% being the luciferase activity in control cells. 
 
Electrophoretic mobility shift assays (EMSA) 
Treated cells were washed with cold PBS and disrupted with lysis buffer (0.5 % Nonidet P-
40, 10mM HEPES, 10mM KCl, 0.1mM EDTA, 0.1mM EGTA, pH7.9, 1mM DDT, 200mM PMSF, 
200mM sodium orthovanadate and protease inhibitors). Lysates were centrifuged 11,000g for 10 min 
at 4◦C and supernatants were maintained at −80◦C until analysis. Pellets containing nuclei were lysed 
with hypertonic buffer (0.5 % Nonidet P-40, 20 mM HEPES, 0.4 M NaCl, 1 mM EDTA, 1 mM 
EGTA, pH 7.9, 1 mM DDT, 200 mM PMSF, 200 mM sodium orthovanadate, and protease 
inhibitors), centrifuged 11,000g at 4◦C for 6 min, and supernatants were conserved at −80◦C until 
assayed. For EMSA the oligonucleotide 5´-CTTTCCCAGCCTGACTCTCCTTCCGTTC-3´, which 
contains the consensus AP-1 sequence into the TGF-β1 promoter, was annealed and radiolabeled 
using the Ready To Go T4 polynucleotide kinase and 10 µCi/µl (γ-32P)-ATP. Nuclear protein 
extracts (10 µg) were incubated with 1 µg poly dI-dC and 0.1 ng of radiolabeled probe (104 to 5×105 
cpm) in a total volume of 20 µl binding buffer (Tris–HCl pH 7.5; 10 mM MgCl2, 200 mM KCl, 1 mM 
EDTA, 1 mM EGTA, 1 mM DTT, 10% glycerol, 5 mM NaF and protease inhibitors) for 30 min at 
room temperature. Samples were run on 8% non-denaturing polyacrylamide gels for 2 h at 200 V. The 
gels were then dried and exposed to X-OMAT films.  
Statistical analysis 
Results are expressed as the mean ± SEM. Statistical analysis was performed by either 
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LIST OF ABBREVIATIONS 
ALLO   Allopurinol 
CAT   Catalase 
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DCFH-DA 5,6-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate 
DPI   Diphenyleneiodonium 
eNOS  Endothelial nitric oxide synthase 
HMC  Human Mesangial Cells 
HUVEC Human umbilical vascular endothelial cells 
PMA  Phorbol 12-myristate 13-acetate 
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Figure 1. Intracellular catalase activity increases and intracellular reactive oxygen species 
(ROS) concentration decreases in human mesangial cells (HMC) treated with catalase. HMC 
were incubated with catalase (160 U/ml to 640 U/ml) for 16h in absence of serum. (A) Intracellular 
catalase activity was measured by colorimetric techniques. Results are mean ± SEM; n = 6 
experiments, *p<0.05 vs control. (B) Intracellular ROS concentration was determined by flow 
cytometry using the dichloro-dihidro-fluorescin diacetate probe. Results are mean ± SEM; n = 6 
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experiments, *p<0.05 vs control. (C) Intracellular H2O2 concentration was measured with confocal 
microscopy, in HMC transfected with HyPer. Single cell images were obtained 48 h after transfection, 
and after incubation with catalase (320 U/mL, 16 h) or H2O2 (100 nM, 30 min). A representative 
experiment is shown, from 6 independent experiments. (To see this illustration in colour the reader is 
referred to the web version of this article at www.liebertonline.com/ars) 
 
 
Figure 2. Transforming growth factor-β1 (TGF-β1) protein expression decrease in human 
messangial cells (HCM) treated with catalase. HMC were treated with several concentrations of 
catalase (160 U/ml to 640 U/ml) or with phorbol 12-myristate 13-acetate (3 nM, PMA) for 16h in 
absence of serum. Protein expression of TGF-β1 was analyzed. (A) Western blotting was performed 
with total cell lysates by using specific antibody against TGFβ-1. Actin was used as loading control. 
Representative Western blot is shown. Bar graphs represent densitometric analysis of bands corrected 
with actin. Results are mean ± SEM; n = 6 experiments, *p<0.05 vs control. (B) Confocal 
microscopic images showing the staining of TGFβ-1 (green) in cells. Treated cells (320 U/ml CAT of 
3 nM PMA) were fixed and incubated with anti-TGF-β1 antibody. A representative experiment is 
shown from 6 independent experiments. (C) Total immunoreactive TGF-β1 was measured in the 
supernatants by ELISA. Bar graph represents TGF-β1 content in cell supernatants after treatment. 
Results are mean ± SEM; n = 6 experiments, *p<0.05 vs control. (To see this illustration in colour the 
reader is referred to the web version of this article at www.liebertonline.com/ars) 
 
 
Figure 3. Catalase treatment decreases transforming growth factor-β1 (TGF-β1) mRNA and 
promoter activity, inhibits the binding of AP-1 to TGF-β1 promoter and reduces the 3TP-Lux 
promoter activity in human mesangial cells (HMC). HMC were treated with several concentrations 
of catalase (160 U/ml to 640 U/ml) for 16h in absence of serum. (A) mRNA was determined by Q-
RT-PCR normalized by the GAPDH content and expressed as fold induction over the levels found in 
control cells. Catalase was used at a concentration of 320 U/ml. Results are mean ± SEM; n = 6 
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experiments, *p<0.05 vs control. (B) HMC was cotransfected with plasmids containing the complete 
sequence of TGF-β1 promoter linked to the luciferase reporter gene and renilla, and treated. 
Luciferase activity was corrected by renilla luciferase activity. Results are expressed as the percentage 
with respect to the control. Results are mean ± SEM; n = 6 experiments, *p<0.05 vs control. (C) The 
same experiments were performed, as in B, but with serial deletions of the human TGF-β1 promoter. 
The two deletion mutants were truncated at the locations shown. The negative (N) or positive (P) 
regulatory regions are represented as black and hatched boxes, respectively. Results are mean ± SEM; 
n = 6 experiments, *p<0.05 vs control. (D) Nuclear proteins were extracted and EMSA was 
performed with specific oligonucleotides for the AP-1 site. To detect the bands an excess of cold 
oligonucleotide was added to the reaction mixture in the catalase sample. A representative EMSA 
from 6 experiments is shown. (E) Luciferase activity of cells transfected with 3TP-Lux promoter 
activity was measured by luciferase assay after treatment with catalase. Results are mean ± SEM; n = 
6 experiments, *p<0.05 vs control.  
 
Figure 4. Inhibition of intracellular ROS by catalase decreases endothelial nitric oxide synthase 
(eNOS) protein content but not change cycloxygenase 1 (COX1) and protein kinase G (PKG-
α1). Cells were treated with catalase at different concentrations (80 U/ml to 640 U/ml) for 16h. 
Protein content was assayed by Western blot with specific antibodies (A) eNOS expression in EAH 
endothelial cells. (B) COX-1 expression and (C) PKG-α1 expression in human mesangial cells. A 
representative blot is shown and bar graphs represent densitometric analysis of bands corrected with 
actin. Results are mean ± SEM; n = 6 experiments, *p<0.05 vs control.  
 
Figure 5. Inhibition of different sources of intracellular ROS produces different response on 
transforming growth factor-β1 (TGF-β1) protein content and promoter activity in human 
mesangial cells (HMC). HMC were incubated with catalase (320 U/mL CAT), diphenyleneiodonium 
(10 µM DPI, NADPH oxidase inhibitor), rotenone (10 µM, ROT, mitochondrial complex I inhibitor), 
allopurinol (100 µM, ALLO, xanthine dehydrogenase inhibitor) or phorbol 12-myristate 13-acetate (3 
nM, PMA). (A) Intracellular ROS concentration was determined by flow cytometry using the 
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dichloro-dihidro-fluorescin diacetate probe. Results are mean ± SEM; n = 6 experiments, *p<0.05 vs 
control. (B) Intracellular H2O2 concentration was measured with confocal microscopy, in HMC 
transfected with HyPer. Single cell images were obtained 48 h after transfection, and after incubation 
with the different reactives for 16 h. A representative experiment is shown, from 6 independent 
experiments. (C) HMC were cotransfected with plasmids containing the complete sequence of TGF-
β1 promoter linked to the luciferase reporter gene and renilla, and treated. Luciferase activity was 
corrected by renilla luciferase activity. Results are expressed as the percentage with respect to the 
control. Results are mean ± SEM; n = 6 experiments, *p<0.05 vs control. (D) Total immunoreactive 
TGF-β1 was measured in the supernatants by ELISA. Bar graph represents TGF-β1 content in cell 
supernatants after treatment. Results are mean ± SEM; n = 6 experiments, *p<0.05 vs control. (To see 
this illustration in colour the reader is referred to the web version of this article at 
www.liebertonline.com/ars) 
 
Figure 6. Transforming growth factor-β1 (TGF-β1) protein expression decreases in mutant 
human fibroblast G7896A with respect to wild-type fibroblast. Human fibroblasts were deprived 
of serum for 16h. Protein expression of TGF-β1 was then analyzed. Protein content was measured by 
Western blot in cell extracts (A) and ELISA in supernatants (B). In the western blot experiments, a 
representative experiment is shown and bar graph represents the densitometric analysis of bands 
corrected with actin. Results are mean ± SEM; n = 6 experiments, *p<0.05 vs control. In the panel C, 
intracellular H2O2 concentration was measured with confocal microscopy, in fibroblasts transfected 
with HyPer. Single cell images were obtained 48 h after transfection. A representative experiment is 
shown, from 6 independent experiments. (To see this illustration in colour the reader is referred to the 
web version of this article at www.liebertonline.com/ars) 
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